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Diagnostic Thresholds for Ambulatory Blood Pressure
Monitoring Based on 10-Year Cardiovascular Risk
Masahiro Kikuya, MD, PhD; Tine W. Hansen, MD, PhD; Lutgarde Thijs, MSc;
Kristina Björklund-Bodegård, MD, PhD; Tatiana Kuznetsova, MD, PhD; Takayoshi Ohkubo, MD, PhD;
Tom Richart, MD, MBE; Christian Torp-Pedersen, MD, PhD; Lars Lind, MD, PhD;
Hans Ibsen, MD, PhD; Yutaka Imai, MD, PhD; Jan A. Staessen, MD, PhD; on behalf of the
International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular
Outcomes (IDACO) Investigators
Background—Current diagnostic thresholds for ambulatory blood pressure (ABP) mainly rely on statistical parameters
derived from reference populations. We determined an outcome-driven reference frame for ABP measurement.
Methods and Results—We performed 24-hour ABP monitoring in 5682 participants (mean age 59.0 years; 43.3% women)
enrolled in prospective population studies in Copenhagen, Denmark; Noorderkempen, Belgium; Ohasama, Japan; and
Uppsala, Sweden. In multivariate analyses, we determined ABP thresholds, which yielded 10-year cardiovascular risks
similar to those associated with optimal (120/80 mm Hg), normal (130/85 mm Hg), and high (140/90 mm Hg) blood
pressure on office measurement. Over 9.7 years (median), 814 cardiovascular end points occurred, including 377 strokes
and 435 cardiac events. Systolic/diastolic thresholds for optimal ABP were 116.8/74.2 mm Hg for 24 hours,
121.6/78.9 mm Hg for daytime, and 100.9/65.3 mm Hg for nighttime. Corresponding thresholds for normal ABP were
123.9/76.8, 129.9/82.6, and 110.2/68.1 mm Hg, respectively, and those for ambulatory hypertension were 131.0/79.4,
138.2/86.4, and 119.5/70.8 mm Hg. After rounding, approximate thresholds for optimal ABP amounted to 115/
75 mm Hg for 24 hours, 120/80 mm Hg for daytime, and 100/65 mm Hg for nighttime. Rounded thresholds for normal
ABP were 125/75, 130/85, and 110/70 mm Hg, respectively, and those for ambulatory hypertension were 130/80,
140/85, and 120/70 mm Hg.
Conclusions—Population-based outcome-driven thresholds for optimal and normal ABP are lower than those currently
proposed by hypertension guidelines. (Circulation. 2007;115:2145-2152.)
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In middle-aged and older subjects, hypertension is thepredominant cardiovascular risk indicator. Blood pres-
sure measurement is the basis for the diagnosis and
treatment of hypertension. Conventional blood pressure
measurement by auscultation of the Korotkoff sounds is
fraught with potential sources of error, which may arise in
the patients, the observer, the sphygmomanometer, or
the overall application of the technique.1 Ambulatory
monitoring allows registration of the blood pressure
throughout the entire day in subjects engaged in their usual
activities. Ambulatory blood pressure recordings have high
reproducibility, are not subject to digit preference, and
avoid the transient rise of a patient’s blood pressure in
response to a medical environment, the so-called white-
coat effect.1
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Although blood pressure is continuously distributed, clini-
cians need a diagnostic reference frame to interpret ambula-
tory blood pressure values and to classify patients. Current
guidelines1–3 propose operational thresholds for the ambula-
tory blood pressure, but these limits are not outcome driven,
relying largely on the distribution of the ambulatory blood
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pressure in normotensive reference populations4,5 or on the
regression of ambulatory on conventional blood pressure.5
We therefore constructed an international population–based
database with the objective to determine diagnostic thresh-
olds for ambulatory blood pressure monitoring in terms of
cardiovascular outcome.
Methods
Study Participants
We constructed the International Database on Ambulatory blood
pressure monitoring in relation to Cardiovascular Outcomes
(IDACO). Eligible studies had to include a random population
sample with longitudinal follow-up of fatal and nonfatal cardiovas-
cular outcomes. An electronic search of the English literature, using
as search terms “ambulatory blood pressure monitoring” and “pop-
ulation,” identified 9 studies.4,6–13 Five8–11,13 could not be included
because at the time of writing of this article, follow-up was still
ongoing8,9,11,13 or because follow-up did not include nonfatal
events.10
For the present analysis, we considered 2311 residents from
Copenhagen, Denmark7; 2542 subjects recruited from Noorderkem-
pen, Belgium4;1535 inhabitants of Ohasama, Japan12; and 1221 men
from Uppsala, Sweden.6 Thus, on April 30, 2006, the number of
subjects available for analysis totaled 7609. All studies contributing
to the IDACO database received ethical approval and have been
described in detail in peer-reviewed publications.4,6,7,12 All partici-
pants gave informed written consent. Of the 7609 subjects, we
excluded 1927 because their conventional (n220) or nighttime
(n1618) blood pressures had not been measured or because their
daytime (n22) or nighttime (n67) blood pressures were the
averages of fewer than 10 or 5 readings, respectively. Thus, the
number of subjects included in the present analyses totaled 5682.
Conventional and Ambulatory Blood
Pressure Measurement
Experienced observers measured the conventional blood pressure
with standard mercury sphygmomanometers4,6,7 or validated14 aus-
cultatory devices (USM-700F, UEDA Electronic Works, Tokyo,
Japan),12 using the appropriate cuff size, after the subjects had rested
for at least 2 minutes in the sitting4,7,12 or supine6 position. The
conventional blood pressure was the average of 2 consecutive
readings obtained either at the subject’s home4 or at an examination
center.6,7,12 We used the thresholds proposed by the Joint National
Committee on the Prevention, Detection, Evaluation and Treatment
of High Blood Pressure (JNC VI),15 the European Society of
Cardiology,3 and the European Society of Hypertension3 to classify
participants according to their conventional blood pressure. Optimal
was a blood pressure level lower than 120 mm Hg systolic and
80 mm Hg diastolic. Normal blood pressure ranged from 120 to
129 mm Hg systolic and from 80 to 84 mm Hg diastolic. Hyperten-
sion was a conventional blood pressure of at least 140 mm Hg
systolic or 90 mm Hg diastolic, irrespective of treatment status.
We programmed portable blood pressure monitors to obtain
readings either at 20-minute6 or 30-minute12 intervals throughout
the day, or at intervals varying from 15 minutes (7 AM to 11 PM)
to 30 minutes (11 PM to 7 AM)7 or from 20 minutes (8 AM to 10 PM)
to 45 minutes (10 PM to 8 AM).4 The devices implemented an
auscultatory algorithm (Accutracker II, Suntech Medical Instruments
Inc, Morrisville, NC) in Uppsala6 or an oscillometric technique
(SpaceLabs 90202 and 90207, SpaceLabs Inc, Redmond, Wash) in
Noorderkempen.4 The Takeda TM-2421 recorders (A&D, Tokyo,
Japan) and the ABPM-630 devices (Nippon Colin, Komaki, Ja-
pan16), used in Copenhagen7 and Ohasama,12 respectively, imple-
mented both techniques, but we only analyzed the oscillometric
readings.
The same SAS macro processed all ambulatory recordings. Mean
24-hour, daytime, and nighttime blood pressures were weighted by
the time interval between consecutive readings. While accounting for
the daily pattern of the activities of study participants, we defined
daytime as the interval ranging from 10 AM to 8 PM in Europeans4,6,7
and from 8 AM to 6 PM in Japanese.12 The corresponding nighttime
intervals ranged from midnight to 6 AM4,6,7 and from 10 PM to 4 AM,12
respectively. These fixed clock-time intervals eliminate the transition
periods in the morning and evening, during which blood pressure
changes rapidly, and result in daytime and nighttime blood pressure
levels that are within 1 to 2 mm Hg of the awake and asleep
levels.9,17
Other Measurements
In all cohorts, a questionnaire was used to obtain detailed informa-
tion on each subject’s medical history, intake of medications, and
smoking and drinking habits. We defined smoking and drinking as
the current use of tobacco and alcohol. Body mass index was body
weight in kilograms divided by height in meters squared. Previous
cardiovascular disease included cardiac and cerebrovascular disor-
ders and peripheral vascular disease. Serum total cholesterol and
blood glucose were determined by automated enzymatic methods on
venous blood samples. Diabetes mellitus was a self-reported diag-
nosis, a fasting or random blood glucose level of at least 7.0 or
11.1 mmol/L (126 or 200 mg/dL),18 respectively, or the use of
antidiabetic drugs.
Ascertainment of Events
We ascertained vital status and incidence of fatal and nonfatal
diseases from the appropriate sources in each country, as described
in detail in previous publications.4,6,7,12,19 Fatal and nonfatal stroke
did not include transient ischemic attacks. Coronary events encom-
passed death due to ischemic heart disease, sudden death, nonfatal
myocardial infarction, and surgical and percutaneous coronary re-
vascularization. Cardiac events comprised coronary end points and
fatal and nonfatal heart failure. In the Danish and Swedish cohorts,
the diagnosis of heart failure required hospitalization. In the Japa-
nese12 and Belgian19 cohorts, heart failure was either a clinical
diagnosis or the diagnosis on the death certificate, but all cases were
validated against hospital records or the records held by general
practitioners. The composite cardiovascular end point included all
aforementioned end points plus cardiovascular mortality. In all
outcome analyses, we only considered the first event within each
category.
Statistical Methods
For database management and statistical analysis, we used SAS
software, version 9.1 (SAS Institute, Cary, NC). We compared
means and proportions by the large-sample z test or ANOVA and by
the 2 test, respectively. To explore the plausibility of the Cox model,
we first plotted incidence rates by fifths of the blood pressure
distributions, while standardizing by the direct method for cohort,
sex, and age (40, 40 to 60, and 60 years). In Cox regression, we
also checked the proportional hazards assumption by the
Kolmogorov-type supremum test. In line with large cohort studies,20
we included blood pressure as a continuous linear term in the Cox
regression model, but we also tested whether the addition of a
quadratic term of blood pressure improved the fit. We calculated
hazard ratios, while adjusting for cohort, sex, age, body mass index,
smoking and drinking, history of cardiovascular disease, diabetes
mellitus, treatment with antihypertensive drugs, and serum total
cholesterol. We adjusted for cohort by introducing 3 design variables
in the Cox models.
We obtained diagnostic thresholds for ambulatory blood pressure
monitoring in 5 steps. First, we computed the 10-year incidence rates
of cardiovascular end points associated with optimal or normal blood
pressure or hypertension on conventional blood pressure measure-
ment. Second, we computed the 10-year incidence rates of cardio-
vascular end points associated with ambulatory blood pressure levels
ranging from the 5th to the 95th percentiles, using intervals of
0.1 mm Hg. In a third step, we selected the ambulatory blood
pressure levels that were associated with similar 10-year risks as the
conventional blood pressure thresholds. Next, we calculated the
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bootstrap distribution21 of the so-obtained ambulatory diagnostic
thresholds by randomly resampling the study population 1000 times
with replacement, using the PROC SURVEYSELECT procedure, as
implemented in the SAS package. For each new sample, we repeated
the first 3 steps. We accounted for tied event times, caused by
resampling with replacement, by the TIESEXACT option in the
PROC PHREG procedure. Finally, we calculated the bootstrap point
estimates and 95% CIs of the ambulatory thresholds as the
mean1.96 SEs of the bootstrap distribution.21
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agreed to the
manuscript as written.
TABLE 2. Hazard Ratios for Cardiovascular End Points in Relation to Conventional and Ambulatory Blood Pressure
at Entry*
Fatal and Nonfatal Cardiovascular End Points Combined†
Cardiovascular
Death All Stroke Cardiac
Coronary Heart
Disease
End points, n (%) 345 (6.1) 814 (14.3) 377 (6.6) 435 (7.7) 328 (5.8)
Systolic blood pressure
Conventional 1.11 (1.05 to 1.17)¶ 1.12 (1.08 to 1.16) 1.16 (1.09 to 1.22) 1.09 (1.04 to 1.15)¶ 1.07 (1.01 to 1.14)‡
24-Hour 1.22 (1.13 to 1.30) 1.24 (1.19 to 1.30) 1.32 (1.23 to 1.41) 1.20 (1.13 to 1.27) 1.17 (1.09 to 1.26)
Daytime 1.16 (1.08 to 1.24) 1.20 (1.15 to 1.25) 1.26 (1.19 to 1.35) 1.16 (1.09 to 1.23) 1.16 (1.08 to 1.25)
Nighttime 1.16 (1.10 to 1.23) 1.18 (1.14 to 1.23) 1.21 (1.15 to 1.28) 1.16 (1.10 to 1.22) 1.12 (1.05 to 1.18)¶
Diastolic blood pressure
Conventional 1.05 (1.00 to 1.10) 1.07 (1.03 to 1.11) 1.12 (1.07 to 1.17) 1.04 (0.99 to 1.09) 1.05 (1.00 to 1.11)
24-Hour 1.18 (1.10 to 1.25) 1.18 (1.13 to 1.23) 1.27 (1.19 to 1.34) 1.11 (1.05 to 1.18)¶ 1.13 (1.05 to 1.20)¶
Daytime 1.12 (1.05 to 1.19)¶ 1.13 (1.09 to 1.17) 1.21 (1.14 to 1.28) 1.07 (1.01 to 1.13)‡ 1.10 (1.03 to 1.17)§
Nighttime 1.14 (1.08 to 1.21) 1.15 (1.10 to 1.19) 1.20 (1.13 to 1.26) 1.10 (1.05 to 1.16) 1.10 (1.04 to 1.16)§
*The analyses included 5682 subjects.
†Hazard ratios (95% CIs) reflect the risk associated with 10- and 5-mm Hg increases in systolic and diastolic blood pressure, respectively. Hazard
ratios were adjusted for cohort, sex, age, body mass index, smoking and drinking, history of cardiovascular disease, diabetes mellitus, treatment with
antihypertensive drugs, and serum total cholesterol.
Significance of the hazard ratios: ‡P0.05; §P0.01; ¶P0.001; P0.0001.
TABLE 1. Baseline Characteristics by Cohort
Characteristic
Copenhagen
(n2137)
Noorderkempen
(n1131)
Ohasama
(n1317)
Uppsala
(n1097)
All
(n5682)
Women, n (%) 1024 (47.9) 573 (50.7) 864 (65.6) 0 (0.0) 2461 (43.3)
Age, y 56.4 (10.3) 49.0 (14.6) 61.8 (9.9) 71.0 (0.6) 59.0 (12.5)
Range 41.0–72.8 13.4–87.7 40.1–93.1 69.4–74.1 13.4–93.1
Body mass index, kg/m2 26.0 (4.1) 25.8 (4.2) 23.5 (3.0) 26.3 (3.4) 25.4 (3.9)
Weight, kg 74.9 (14.1) 72.2 (13.4) 54.2 (9.0) 80.3 (11.6) 70.6 (15.6)
Height, cm 169.5 (9.0) 167.0 (9.4) 151.7 (8.6) 174.8 (5.9) 165.9 (11.8)
Conventional blood pressure, mm Hg
Systolic 131.2 (19.2) 126.7 (17.8) 131.2 (18.5) 146.7 (18.5) 133.3 (19.8)
Diastolic 83.3 (10.7) 76.7 (10.6) 74.1 (11.4) 83.7 (9.4) 79.9 (11.4)
24-Hour blood pressure, mm Hg
Systolic 128.6 (12.8) 118.8 (11.1) 123.1 (13.2) 132.9 (15.6) 126.2 (14.0)
Diastolic 75.1 (8.6) 71.3 (7.4) 71.9 (7.8) 75.1 (7.7) 73.6 (8.2)
Daytime blood pressure, mm Hg
Systolic 136.4 (13.6) 125.0 (11.7) 128.9 (14.3) 140.2 (16.2) 133.1 (15.0)
Diastolic 80.5 (9.2) 77.1 (8.2) 76.1 (8.7) 79.8 (8.7) 78.7 (9.0)
Nighttime blood pressure, mm Hg
Systolic 115.8 (14.1) 108.5 (12.2) 111.6 (14.7) 119.3 (18.6) 114.0 (15.3)
Diastolic 65.7 (9.1) 61.8 (8.2) 63.6 (8.2) 66.9 (9.0) 64.7 (9.0)
Serum total cholesterol, mmol/L* 6.21 (1.11) 5.68 (1.12) 5.00 (0.88) 5.82 (1.00) 5.75 (1.14)
Diabetes mellitus, n (%) 64 (3.0) 36 (3.2) 232 (17.6) 121 (11.0) 453 (8.0)
Previous cardiovascular disease, n (%) 128 (6.0) 119 (10.5) 72 (5.5) 191 (17.4) 510 (9.0)
Antihypertensive drug treatment, n (%) 319 (14.9) 170 (15.0) 466 (35.4) 383 (34.9) 1338 (23.5)
Data are expressed as mean (SD) unless otherwise noted. All between-cohort differences were significant (P0.0001).
*To convert serum total cholesterol levels to milligrams per deciliter, divide by 0.02586.
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Results
Baseline Characteristics of Participants
Table 1 shows the baseline characteristics of each cohort. The
5682 participants included 2461 women (43.3%), 2228 pa-
tients (39.2%) with hypertensive blood pressure levels on
conventional measurement, and 1338 patients (23.5%) taking
blood pressure–lowering drugs. Of 4344 untreated partici-
pants, 1164 (26.8%) and 961 (22.1%) had an optimal or
normal conventional blood pressure, respectively. Systolic
and diastolic blood pressures were on average 0.2 mm Hg
(P0.43) and 1.3 mm Hg (P0.0001) higher on conven-
tional than on daytime ambulatory measurement.
At enrollment, 1746 participants (30.7%) were current
smokers, and 2948 (51.9%) reported intake of alcohol. Across
cohorts, the prevalence of smoking (17.8% versus 43.4%), as
well as that of drinking (20.0% versus 85.9%), was lowest in
Ohasama and highest in Copenhagen. Between-cohort differ-
ences were significant for all variables (P0.0001).
Incidence of End Points in Relation to
Blood Pressure
In the overall study population, median follow-up was 9.7
years (5th to 95th percentile interval, 2.3 to 14.1 years).
Across cohorts, median follow-up ranged from 9.3 years (5th
to 95th percentile interval, 3.1 to 10.1 years) in Copenhagen
to 13.1 years (5th to 95th percentile interval, 0.8 to 15.7
years) in Noorderkempen. Of 873 deaths (15.5 per 1000
person-years), 345 were cardiovascular, 496 were noncardio-
vascular, and 32 were due to unknown causes. Table 2 gives
the number of cardiovascular end points in all cohorts
combined. The unadjusted incidence of fatal and nonfatal
cardiovascular complications averaged 15.1 events per 1000
person-years, ranging from 7.5 in Noorderkempen to 33.6 in
Uppsala.
The Figure shows the increase in cardiovascular events,
stroke, and cardiac end points across fifths of the distributions
of the conventional and 24-hour systolic and diastolic blood
pressures with standardization for cohort, sex, and age. In
Cox regression, the Kolmogorov-type supremum test showed
that for all outcomes in relation to blood pressure, the
proportional hazards assumption was satisfied (P0.11).
With adjustments applied for cohort, sex, age, body mass
index, smoking and drinking, history of cardiovascular dis-
ease, diabetes mellitus, treatment with antihypertensive
drugs, and serum total cholesterol, blood pressure was a
highly significant and consistent predictor of cardiovascular
outcome, irrespective of the type of measurement (Table 2).
Noncardiovascular mortality was unrelated to the conven-
tional or 24-hour ambulatory blood pressures, with hazard
ratios close to unity (P0.43).
Diagnostic Thresholds for Ambulatory Blood
Pressure Measurement
Using a bootstrap procedure, we calculated the ambulatory
blood pressure levels that yielded 10-year absolute risks of
cardiovascular, cerebrovascular, or cardiac events similar to
those associated with optimal or normal blood pressure or
hypertension on conventional blood pressure measurement.
Table 3 shows the point estimates and 95% CIs for those risk
thresholds adjusted for cohort. Further adjustment for sex,
age, and other cardiovascular risk factors produced consistent
results (data not shown). The thresholds based on the full data
set were similar to the means of the bootstraps. Table 4
provides similar risk estimates but excludes the 1338 patients
who were undergoing antihypertensive drug treatment at
baseline.
To obtain more easily recallable thresholds, in the last step
of our analysis, we rounded the point estimates for cardio-
vascular events, stroke, and cardiac disease reported in Table
3 to an integer value ending in 0 or 5. Table 5 lists these
rounded thresholds. In sensitivity analyses, from which we
excluded 1 cohort at a time, these diagnostic thresholds
remained largely consistent. After exclusion of the Uppsala
cohort, the rounded thresholds for optimal systolic pressure,
compared with those proposed in Table 5, were 5 mm Hg
higher for whole-day (120 instead of 115 mm Hg) and
daytime (125 instead of 120 mm Hg) recordings. With
exclusion of the Copenhagen cohort, the rounded threshold
for the daytime systolic pressure became 5 mm Hg lower
(135 instead of 140 mm Hg). Rounding the values reported in
Table 4 for subjects untreated at baseline also produced
thresholds similar to those in Table 5, except for the optimal
Incidence of cardiovascular events, stroke, and cardiac end
points by fifths of the distributions of conventional office blood
pressure (A) or 24-hour ambulatory blood pressure (B). Inci-
dence rates were standardized by the direct method for cohort,
sex, and age (40, 40 to 60, and 60 years). The number of
events contributing to the incidence rates is presented.
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systolic levels of the 24-hour and daytime blood pressures,
which became 5 mm Hg higher. The addition of a quadratic
term of blood pressure to the Cox models slightly but
significantly improved the fit for the 24-hour (P0.007) and
nighttime (P0.01) systolic blood pressures but did not
materially alter the results.
Discussion
Guidelines for the diagnosis and management of hypertension
reflect consensus about the thresholds for optimal and normal
blood pressure and hypertension on conventional office
measurement. High-normal blood pressure on office mea-
surement, compared with optimal blood pressure, was asso-
ciated with increased rates of cardiovascular complications.22
Building on this large consensus, we used the 10-year
cardiovascular risks associated with the established limits for
the office blood pressure, and we rounded the so-obtained
thresholds to 0 or 5 to derive more easily recallable outcome-
driven blood pressure thresholds for ambulatory monitoring.
One should carefully interpret the currently proposed
ambulatory thresholds. First, the relation between cardiovas-
cular outcome and blood pressure is continuous. There is no
critical level above which the risk suddenly rises. Thresholds
only serve the need of clinicians to use cutoff limits for the
diagnosis and management of hypertension. Second, the
classification of conventional blood pressure into optimal,
normal, high-normal, or hypertensive levels is not sex and
age specific. In the present outcome analyses, we therefore
only adjusted for cohort and disregarded sex, age, and other
cardiovascular risk factors. However, further adjustment pro-
duced consistent results, with little change in the proposed
ambulatory cutoff limits. Sensitivity analyses, from which we
excluded 1 cohort at a time or patients taking antihyperten-
sive drug treatment, were also largely confirmatory.
The conventional blood pressure in the present study was
the average of 2 readings obtained at a single examination.
More readings were available in the Belgian cohort, in which
the baseline observations included 2 home visits at an interval
TABLE 3. Ambulatory Blood Pressure Levels Yielding 10-Year Risks Similar to Those Associated With Optimal or Normal Blood
Pressure or Hypertension on Conventional Measurement in All Subjects*
Ambulatory Blood Pressure Levels (95% CI), mm Hg
End Point (n) Category
Conventional Blood
Pressure, mm Hg
10-Year Absolute
Risk, % 24-Hour Daytime Nighttime
Cardiovascular (814) Optimal
Systolic 120 9.4 116.8 (114.6 to 119.0) 121.6 (119.1 to 124.2) 100.9 (97.5 to 104.2)
Diastolic 80 13.1 74.2 (73.9 to 74.6) 78.9 (78.5 to 79.4) 65.3 (64.9 to 65.7)
Normal
Systolic 130 11.6 123.9 (122.8 to 125.0) 129.9 (128.7 to 131.2) 110.2 (108.5 to 111.8)
Diastolic 85 14.3 76.8 (76.3 to 77.4) 82.6 (81.9 to 83.4) 68.1 (67.5 to 68.7)
Hypertension
Systolic 140 14.3 131.0 (130.6 to 131.4) 138.2 (137.8 to 138.7) 119.5 (118.8 to 120.1)
Diastolic 90 15.7 79.4 (78.2 to 80.7) 86.4 (84.5 to 88.2) 70.8 (69.4 to 72.3)
Stroke (377) Optimal
Systolic 120 4.0 117.5 (114.7 to 120.4) 122.6 (119.2 to 126.0) 100.9 (96.7 to 105.1)
Diastolic 80 5.7 74.4 (73.8 to 74.9) 79.1 (78.4 to 79.8) 65.3 (64.6 to 65.9)
Normal
Systolic 130 5.0 124.3 (122.8 to 125.8) 130.4 (128.6 to 132.2) 110.2 (108.0 to 112.3)
Diastolic 85 6.6 77.1 (76.7 to 77.6) 82.7 (82.1 to 83.3) 68.5 (67.9 to 69.0)
Hypertension
Systolic 140 6.4 131.1 (130.7 to 131.5) 138.2 (137.8 to 138.7) 119.4 (118.8 to 120.0)
Diastolic 90 7.5 79.9 (78.7 to 81.1) 86.2 (84.6 to 87.9) 71.7 (70.2 to 73.2)
Cardiac (435) Optimal
Systolic 120 4.4 115.8 (112.6 to 118.9) 120.7 (116.8 to 124.5) 99.9 (95.3 to 104.5)
Diastolic 80 6.2 74.0 (73.6 to 74.5) 78.7 (77.9 to 79.4) 65.2 (64.7 to 65.8)
Normal
Systolic 130 5.4 123.4 (121.8 to 125.0) 129.4 (127.5 to 131.4) 109.7 (107.4 to 112.0)
Diastolic 85 6.7 76.7 (75.6 to 77.9) 83.1 (80.7 to 85.5) 67.8 (66.7 to 69.0)
Hypertension
Systolic 140 6.7 131.0 (130.5 to 131.4) 138.2 (137.7 to 138.8) 119.5 (118.8 to 120.2)
Diastolic 90 7.2 79.4 (76.8 to 82.0) 87.5 (82.7 to 92.3) 70.5 (67.7 to 73.2)
*The analyses were adjusted for cohort. Point estimates and 95% CIs were obtained from the bootstrap distribution of 1000 random samples of the study population
with replacement (for further details, see Methods).
Kikuya et al Diagnostic Thresholds for Ambulatory BP 2149
 at SWETS SUBS SERV-#26968045 on April 23, 2007 circ.ahajournals.orgDownloaded from 
of 2 to 4 weeks.23 At each visit, the observers obtained 5
consecutive blood pressure readings. Blood pressure signifi-
cantly decreased from the first to the second home visit, but
the average difference was only 2 mm Hg for both systolic
and diastolic blood pressures. Lack of repeated conventional
blood pressure measurements at different occasions in the
other cohorts precluded a correction for regression dilution
bias of the association between cardiovascular outcome and
the conventional blood pressure; however, the small differ-
ences between the repeated measurements in the Belgian
cohort23 suggest that such correction would not greatly affect
the present results.
Previous studies24–27 in hypertensive patients based their
definitions of a normal ambulatory blood pressure on nonin-
vasive27 or intra-arterial25 24-hour recordings or on daytime
recordings24,26 spanning periods ranging from 10 hours26 to 16
hours.24 The thresholds of normality in studies of hypertensive
patients that used an intermittent technique of ambulatory
monitoring ranged from 131 mm Hg24 to 140 mm Hg26 systolic
and from 86 mm Hg24 to 90 mm Hg26 diastolic in daytime
recordings. The aforementioned studies in hypertensive patients,
although outcome driven, are difficult to interpret, because blood
pressure was not analyzed as a continuous variable,25,27 because
some studies25,26 did not include a normotensive control group,
or because investigators did not attempt to further subdivide the
normotensive control subjects into those with normal or elevated
ambulatory blood pressure.24,27
Four population-based reports6,7,10,28 used outcome data to
address normality of the ambulatory blood pressure. In a
cross-sectional observational study of the population of
TABLE 4. Ambulatory Blood Pressure Levels Yielding 10-Year Risks Similar to Those Associated With Optimal or
Normal Blood Pressure or Hypertension on Conventional Measurement in 4344 Subjects Untreated at Baseline*
End Point (n) Category
Conventional
Blood Pressure,
mm Hg
10-Year
Absolute
Risk, %
Ambulatory Blood Pressure Levels (95% CIs), mm Hg
24-Hour Daytime Nighttime
Cardiovascular (462) Optimal
Systolic 120 7.5 118.8 (116.6 to 121.0) 125.5 (123.2 to 127.8) 103.2 (99.6 to 106.9)
Diastolic 80 9.9 74.4 (74.1 to 74.8) 79.6 (79.2 to 79.9) 65.5 (65.1 to 65.9)
Normal
Systolic 130 9.3 125.3 (124.4 to 126.2) 132.5 (131.5 to 133.4) 112.1 (110.8 to 113.5)
Diastolic 85 10.7 76.4 (75.5 to 77.3) 82.1 (81.0 to 83.2) 67.6 (66.6 to 68.6)
Hypertension
Systolic 140 11.5 131.9 (131.1 to 132.6) 139.5 (138.7 to 140.2) 121.0 (119.7 to 122.3)
Diastolic 90 11.6 78.3 (76.7 to 80.0) 84.6 (82.5 to 86.8) 69.7 (67.7 to 71.6)
Stroke (204) Optimal
Systolic 120 3.2 119.5 (116.7 to 122.3) 126.6 (123.7 to 129.4) 103.6 (99.2 to 108.1)
Diastolic 80 4.4 74.7 (74.2 to 75.2) 79.8 (79.2 to 80.4) 65.8 (65.3 to 66.4)
Normal
Systolic 130 4.0 125.7 (124.5 to 127.0) 133.0 (131.7 to 134.3) 112.3 (110.5 to 114.1)
Diastolic 85 4.9 76.8 (75.9 to 77.7) 82.5 (81.4 to 83.6) 68.1 (67.1 to 69.1)
Hypertension
Systolic 140 5.1 132.0 (131.2 to 132.7) 139.5 (138.8 to 140.2) 120.9 (119.8 to 122.1)
Diastolic 90 5.4 78.9 (77.1 to 80.7) 85.1 (82.8 to 87.5) 70.3 (68.3 to 72.3)
Cardiac (249) Optimal
Systolic 120 3.2 117.6 (114.5 to 120.7) 124.3 (120.8 to 127.7) 101.5 (96.3 to 106.7)
Diastolic 80 4.3 74.2 (73.8 to 74.6) 79.4 (78.9 to 79.8) 65.2 (64.7 to 65.7)
Normal
Systolic 130 4.0 124.8 (123.6 to 126.1) 132.0 (130.6 to 133.4) 111.5 (109.5 to 113.4)
Diastolic 85 4.6 76.6 (74.9 to 78.2) 82.4 (80.2 to 84.6) 67.9 (65.9 to 69.9)
Hypertension
Systolic 140 4.9 132.1 (131.2 to 133.0) 139.7 (138.8 to 140.7) 121.4 (119.7 to 123.2)
Diastolic 90 5.0 78.9 (75.6 to 82.2) 85.5 (81.0 to 89.9) 70.6 (66.5 to 74.6)
*The analyses were adjusted for cohort. Point estimates and 95% CIs were obtained from the bootstrap distribution of 1000 random samples of
the study population with replacement (for further details, see Methods).
TABLE 5. Proposal for Outcome-Driven Reference Values for
Ambulatory Blood Pressure Measurement*
24-Hour Daytime Nighttime
Optimal blood pressure, mm Hg 115/75 120/80 100/65
Normal blood pressure, mm Hg 125/75 130/85 110/70
Ambulatory hypertension, mm Hg 130/80 140/85 120/70
Threshold values were obtained by rounding the point estimates reported in
Table 3 to an integer value ending in 0 or 5.
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Monza, Italy, Sega and colleagues5 regressed ambulatory on
office blood pressure. They found that the cutoff limits of the
24-hour blood pressure that corresponded with office hyper-
tension were 125 mm Hg systolic and 76 mm Hg diastolic.5
Follow-up of the Monza cohort demonstrated that total and
cardiovascular mortality gradually increased from sustained
normotension over white-coat and masked hypertension to
sustained hypertension.10 Two Scandinavian population stud-
ies6,7 used as thresholds of normality daytime blood pressure
levels of 135 mm Hg systolic and 85 mm Hg diastolic.
Ohkubo and coworkers28 observed that the optimal 24-hour
blood pressure that resulted in the lowest all-cause mortality
ranged from 120 to 133 mm Hg systolic and from
65 to 78 mm Hg diastolic. Levels above and below these
24-hour thresholds were associated with higher cardiovascu-
lar or noncardiovascular mortality, respectively.28 Of the 4
studies,6,7,10,28 only the Ohasama report28 proposed cutoff
limits directly derived from outcome. The introduction of
stroke units and the wide availability of invasive coronary
care and thrombolysis recently reduced the case-fatality rate
of most cardiovascular complications of hypertension. The
lack of accounting for nonfatal events10,28 and the low number
of exclusively fatal cardiovascular end points in some studies
(n69)10 therefore limits the generalizability of the previous
reports.
The present study must be interpreted within the context of
its potential limitations. First, the present analysis rested only
on 4 population-based cohorts and might therefore not be
representative for non-European or non-Japanese subjects.
Second, our study population predominantly included older
adults. Of the participants, only 2.1% and 5.9% were younger
than 30 or 40 years, respectively. The Uppsala cohort6
consisted only of men. Anthropometric characteristics dif-
fered between cohorts. The high prevalence of smoking
probably explained why the daytime blood pressure was
higher in the Copenhagen cohort than the conventional blood
pressure.29 Ambulatory blood pressure monitoring was not
standardized in terms of device type and intervals between
readings. On the other hand, the use of a single SAS macro
ensured that daytime and nighttime periods were always
defined in the same fashion, using short, fixed clock-time
intervals,9,17 and that the time-weighted means over all
periods of the day were calculated identically across cohorts.
Finally, the rounded blood pressure thresholds are a compro-
mise between accuracy and practicability. Whenever round-
ing suggested different thresholds (5 mm Hg), we always
opted for the lowest value.
In conclusion, the present report provides point estimates
with 95% CIs for 3 major cardiovascular end points in
relation to the ambulatory blood pressure. The systolic/dia-
stolic cutoff limits for normality in the current guidelines for
the management of hypertension are 125/80 mm Hg for
24-hour blood pressure in Europe1 and 135/85 mm Hg and
120/75 mm Hg for awake and asleep blood pressures in the
United States.2,15 The present findings suggest that outcome-
driven thresholds for optimal and normal levels of the
ambulatory blood pressure are lower than those currently
proposed by hypertension guidelines.
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CLINICAL PERSPECTIVE
Although blood pressure is continuously distributed, clinicians need a diagnostic reference frame to interpret ambulatory
blood pressure values and to classify patients. The systolic/diastolic cutoff limits for normality in the current guidelines for
the management of hypertension are 125/80 mm Hg for 24-hour blood pressure in Europe and 135/85 mm Hg and
120/75 mm Hg, respectively, for awake and asleep blood pressures in the United States. The currently proposed levels for
an optimal blood pressure on ambulatory monitoring are substantially lower than the thresholds recommended in the
guidelines. The diagnostic blood pressure levels based on population studies should be further validated in event-based
studies set up in referred patients with a traditional office diagnosis of hypertension. It is indeed in these patients that the
ambulatory thresholds will be predominantly used for risk stratification. Until this evidence becomes available, the
population-based thresholds might inform guidelines and help clinicians in the management of patients with suspected or
established hypertension.
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